San Francisco, CA, United States of America

JoAnn Wilson

This inventor holds 1 USPTO granted patent. Top assignee: Symphony Evolution, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: JoAnn Wilson. Retrieved from https://idiyas.com/inventor/joann-wilson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: JoAnn Wilson: Innovator in Human ADAM-10 Inhibitors

Introduction

JoAnn Wilson is a prominent inventor based in San Francisco, California. She has made significant contributions to the field of biotechnology, particularly in the development of compounds that target critical proteins involved in various diseases.

Latest Patents

JoAnn Wilson holds a patent for "Human ADAM-10 inhibitors - Magnesium salts/complexes of compounds useful for inhibiting the ADAM-10 protein and methods of making and purifying them." This patent outlines the use of magnesium salts and complexes of these compounds in combination with a pharmaceutically acceptable carrier. The compounds and their compositions are designed for the treatment of cancer, arthritis, and diseases related to angiogenesis, including renal diseases, heart diseases, inflammation, and diabetes.

Career Highlights

JoAnn Wilson is currently associated with Symphony Evolution, Inc., where she continues to advance her research and development efforts. Her work focuses on innovative solutions that address significant health challenges.

Collaborations

JoAnn collaborates with notable colleagues, including Sriram Naganathan and Daniel A Dickman, to further enhance the impact of her research.

Conclusion

JoAnn Wilson's innovative work in the field of human ADAM-10 inhibitors showcases her dedication to improving health outcomes through scientific advancements. Her contributions are paving the way for new treatments that could benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…